Pyomyositis in childhood

The Journal of Tropical Medicine and Hygiene
|June 1, 1980
PubMed

Insights

In Nigerian children with pyomyositis, 25% developed osteomyelitis, often with severe complications like anemia and sepsis. Prompt management of electrolyte imbalances is crucial for better outcomes in pediatric pyomyositis cases.

Area of Science:

  • Pediatric infectious diseases
  • Musculoskeletal infections
  • Global health

Background:

  • Pyomyositis, a bacterial infection of muscle, can lead to significant morbidity in children.
  • Associated osteomyelitis is a known complication, but its frequency and impact in Nigerian children require further investigation.
  • Understanding co-existing conditions like anemia and sepsis is vital for comprehensive management.

Purpose of the Study:

  • To determine the incidence of osteomyelitis in Nigerian children with pyomyositis.
  • To identify common complications and associated disorders in this patient population.
  • To highlight the importance of managing electrolyte and urea abnormalities in pediatric pyomyositis.

Main Methods:

  • Retrospective analysis of 63 Nigerian children diagnosed with pyomyositis.
  • Clinical data collection including age, presenting symptoms, and laboratory findings.
  • Assessment for the presence of associated osteomyelitis and other complications.

Main Results:

  • Twenty-five percent (25%) of the 63 children presented with concurrent osteomyelitis.
  • Anemia and septicemia were frequent complications, with septicemia present at diagnosis in all osteomyelitis cases.
  • High rates of electrolyte and urea abnormalities were observed, requiring management.

Conclusions:

  • Pyomyositis in Nigerian children has a high rate of associated osteomyelitis and severe complications.
  • Septicemia at presentation is a significant indicator for osteomyelitis development.
  • Multifactorial electrolyte and urea abnormalities necessitate correction for optimal pyomyositis management in children.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...